Amarin--2019's Biggest Buyout Target for Big Pharma
Amarin (AMRN US), a US-listed biotech firm, presented the full results of its "Reduce-It" (RI) clinical trial at a conference for the American...
4.9k Views
Nippon Suisan (1332)--Update on Amarin's Reduce-It Trial Data Scheduled for Release by Month-End
We recently published an Insight (Nippon Suisan (1332)--The Biggest Event in Japan's Food & Beverage Sector Comes Within 4 Weeks) on Japanese...
1.3k Views